Antibody-Based Drug Helps "Bridge" Leukemia Patients to Curative Treatment

In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell transplants.
News Wise
Antibody-Based Drug Helps "Bridge" Leukemia Patients to Curative Treatment
#adoption #adoptionagency #adopt #adoptachild
#adoptionagency_
@adoptionagency_

The post Antibody-Based Drug Helps "Bridge" Leukemia Patients to Curative Treatment appeared first on Adoption Agency.

Adoption Agencies Guide
Antibody-Based Drug Helps "Bridge" Leukemia Patients to Curative Treatment

The post Antibody-Based Drug Helps "Bridge" Leukemia Patients to Curative Treatment appeared first on Improvisation.